Advertisement

Topics

Jayson Dallas Leaves Ultragenyx for CEO Post at Aimmune

16:12 EDT 13 Jun 2018 | Xconomy

Jayson Dallas has been appointed CEO of food allergy therapy developer Aimmune Therapeutics. Before joining Brisbane, CA-based Aimmune, Dallas was the chief commercial officer of Ultragenyx (NASDAQ: RARE) in Novato, CA. Dallas succeeds Stephen Dilly, who last year announced his plans to retire from Aimmune. The company says Dilly will continue to serve as an […]

Original Article: Jayson Dallas Leaves Ultragenyx for CEO Post at Aimmune

NEXT ARTICLE

More From BioPortfolio on "Jayson Dallas Leaves Ultragenyx for CEO Post at Aimmune"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Food
Food is any substance consumed to provide nutritional support for the body. It is usually of plant or animal origin, and contains essential nutrients, such as carbohydrates, fats, proteins, vitamins, or minerals. The substance is ingested by an organism ...

Allergies
The term allergy is used to describe a response, within the body, to a substance, which is not necessarily harmful in itself, but results in an immune response and a reaction that causes symptoms and disease in a predisposed person, which in turn can cau...